Due to advances in biological technologies such as high-throughput sequencing and the discovery of abnormal expression of METTL3, ALKBH5, and FTO, the role of m6A methylation in ESCC has gradually been revealed (Zhang et al., 2021). The gene discussed is METTL3; the disease is esophageal squamous cell carcinoma.